Skip to main content

GBT Tokenize Completed First Phase of qTerm – Shape and Sizes

SAN DIEGO, Aug. 12, 2020 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT” or the “Company”), announced that its Joint Venture, GBT Tokenize Corp (“GBT/Tokenize”), has completed Phase I of qTerm, a human vitals device, powered by AI, which is the device size and physical dimensions.
The qTerm device is targeted to measure body temperature, blood pressure, and heart rate – all with a simple touch of the finger. GBT believes that the miniaturization of the device is a key factor to its success, yet advanced circuitry and sensory systems have to fit on board. We simulated and evaluated sizes and shapes of qTerm and concluded a user friendly, efficient sizes and shape for version one.  The device could be easily attached to a smart phone or used as a standalone instrument. Version one will use a standard button battery and will be typically at OFF state. When the user touches and holds the button, it will be activated and measure human’s vital signs. In order to join the world’s battle against the COVID-19 virus, we are accelerating version one development with the goal of to bring the product into the market as soon as possible.  Version one will be measuring human temperature. If the reading is of concern, the user will receive a timely visual and audio alert.  qTerm smart phone app will keep a history for the user’s records and provide numerical and statistical data about the user’s body temperature.In addition, qTerm’s mobile app is designed to be powered by AI, anonymously and securely collecting the user data, building a worldwide ‘thermal map’ to alert about potential health risks proximities. The device sizes and shape, including battery location and PCB board has been determined and now GBT is moving to Phase II, which is the device circuits implementation and optimization.As a reminder, on April 19, 2020, GBT/Tokenize filed a provisional patent with USPTO for proximity circle. The application has been assigned serial number 63012205. The system includes an AI engine that enables “Safety Circle” per users. The system records users body temperature and we believe can be used to build HOT ZONES database. The system is using the mobile device or its own GPS system to categorize and define regions with people that reported above normal hot body temperature. This seeks to provide an addition layer of protection to a provisional patent application for the qTerm Device that was filed on March 30, 2020 with the USPTO, which has been assigned serial number 63001564. On August 3, 2020, GBT/Tokenize filed a comprehensive non-provisional patent with USPTO for the qTerm project. The application has been assigned serial number 16983289.  The patent includes a wide variety of features to be implemented within the device according to the company’s scheduled releases and milestones. The device is scheduled to complete its prototyping by September 2020.Rendering of the suggested shape (for visualization only):https://www.globenewswire.com/NewsRoom/AttachmentNg/cf0ed2f2-d60b-4613-9518-d9c706e89994About GBT Technologies Inc.GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”) ( http://gbtti.com ) is a development-stage company which considers itself a native IoT creator, developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology platforms.  GBT has a portfolio of Intellectual Property that, when commercialized, will include smart microchips, mobile and security applications and protocols, and supporting cloud software.  GBT’s system envisions the creation of a global mesh network.  The core of the system will be its advanced microchip technology that can be installed in any mobile or fixed device worldwide. GBT envisions this system as a low-cost, secure, private mesh network between any enabled devices, providing shared processing, advanced mobile database management/sharing and enhanced mobile features as an alternative to traditional carrier services.Forward-Looking StatementsCertain statements contained in this press release may constitute “forward-looking statements”.  Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov).  In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products.  The forward-looking statements included in this press release represent the Company’s views as of the date of this press release and these views could change.  However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.  These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the press release.Contact:
Dr. Danny Rittman, CTO
GBT Technologies Inc.
Media: press@gopherprotocol.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.